Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.117 | Role of N6-methyladenosine modification in colorectal cancer: functions, mechanisms and implications |
Prof. YU Jun 于君 |
| 2008.531 | Clarification of the role of H. pylori infection on the activation of STAT3 through dissecting STAT3 signaling network in gastric cancer | Dr YU Jun |
| 2008.536 | Epstein-Barr Virus and Gastric Cancer: Viral Carcinogenesis through DNA Methylation | Dr YU Jun |
| 2024.570 | Faecalibacterium prausnitzii potentiates chemotherapy response in colorectal cancer: molecular mechanisms and translational implications | Prof. YU Jun |
| 2023.114 | RNA m6A去甲基化酶ALKBH5对结直肠癌化疗疗效的影响及作用机制 (Targeting RNA m6A eraser ALKBH5 boosts the efficacy of chemotherapy in colorectal cancer) |
Prof. YU Jun 于君 |
| 2023.017 | Deciphering the role of gut microbiota in modulating antitumor immune response in colorectal cancer: mechanisms and translational value |
Prof. YU Jun 于君 |
| 2023.016 | Microbiota in Gastrointestinal Cancers: Mechanistic Investigation and Clinical Applications |
Prof. YU Jun 于君 |
| 2023.457 | Targeting m6A modification to boost chemotherapy and immunotherapy efficacy in colorectal cancer |
Prof. YU Jun 于君 |
| 2023.022 | RNA N6-Methyladenosine Demethylase AlkB Homolog 5 (ALKBH5) promotes stemness and chemoresistance in colorectal cancer: mechanism and novel therapeutic approaches |
Prof. YU Jun 于君 |
| 2022.108 | RNA m6A甲基化识别蛋白YTHDF1在调控结直肠癌免疫微环境中的作用及机制研究 (Elucidating the role and mechanism of RNA m6A reader YTHDF1 in regulating the immune microenvironment of colorectal cancer) |
Prof. YU Jun 于君 |
| 2023.631 | Targeting Cancer Stem Cells in Non-alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications |
Prof. YU Jun 于君 |
| 2022.203 | Altered gut microbiome composition by appendectomy contributes to colorectal cancer |
Prof. YU Jun 于君 |
| 2022.026 | RNA N6-Methyladenosine (m6A) Methyltransferase METTL3 facilitates non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLDHCC) via a m6A-cholesterol axis to repress T-cell function |
Prof. YU Jun 于君 |
| 2021.451 | Developing probiotics into high-efficacy and safe prophylactics and adjuvant therapies for colorectal cancer |
Prof. YU Jun 于君 |
| 2022.025 | Modulation of antitumor immune response by gut microbiota: characterization, molecular mechanism and translational value |
Prof. YU Jun 于君 |
| 2018.359 | Centre for Gut Microbiome in Cancers |
Prof. YU Jun 于君 |
| 2020.062 | Characterization on the role of RNA Demethylase AlkB Homolog 5 (ALKBH5) in colorectal cancer |
Prof. YU Jun 于君 |
| 2020.024 | Elucidating the role of gut microbial dysbiosis in colorectal cancer |
Prof. YU Jun 于君 |
| 2019.617 | Evaluation of SQLE as a novel therapeutic target in non-alcoholic fatty liver disease |
Prof. YU Jun 于君 |
| 2020.685 | Deciphering the role and molecular mechanisms of predominant bacterial pathogens in colorectal cancer pathogenesis and augment therapies |
Prof. YU Jun 于君 |
| 2020.684 | RNA Demethylase AlkB Homolog 5 (ALKBH5) drives immune suppression in colorectal cancer via epitranscriptome regulation of AXIN2-WNT-DKK1 axis |
Prof. YU Jun 于君 |
| 2019.132 | A study of the clinical significance and molecular mechanism of TRIP6 in colorectal cancer invasion and metastasis. |
Prof. YU Jun 于君 |
| 2019.425 | Exploiting epitranscriptome dysregulation in colorectal carcinogenesis and metastasis: mechanisms and novel therapeutic approaches |
Prof. YU Jun 于君 |
| 2018.463 | Gut microbiota and Hepatocellular carcinoma | Prof. YU Jun |
| 2019.093 | Non-invasive diagnosis of colorectal cancer using microbial markers |
Dr. YU Jun 于君 |
| 2019.073 | Defining the role of RNA N6-methyladenosine writer methyltransferase like 3 (METTL3) in colorectal cancer |
Prof. YU Jun 于君 |
| 2014.219 | Association between PM2.5 and lung function / Black Carbon exposure to concentration of exhaled NO in roadside newspaper vendors in Hong Kong | Mr. YU Ka Hei |
| 2010.484 | Comparison of the Hearing Performance between the Oticon Baha Ponto and a control Cochlear baha BP100 at CUHK in Hong Kong | Dr. Yu Ka Yin |
| 2011.012 | LONG TERM PATIENT SATISFACTION WITH COCHLEAR IMPLANTATION ELDERLY | Dr. Yu Ka Yin |
| 2008.206 | A Review of Two Neonatal Hearing Screening Programmes in Hong Kong | Dr. Yu Ka Yin, Joannie |
| 2017.635 | Dosimetric study for treating left-sided breast cancer with internal mammary node involvement using intensity modulated radiation therapy and volumetric arc therapy | Mr. YU Kai Shing |
| 2019.622 | Dosimetric Effects of Collimator Angles in Volumetric Modulated Arc Therapy Planning in Cancers of the Left Breast |
Mr. YU Kai Shing 余啟成 |
| 2018.593 | Dosimetric Comparison Between f-IMRT and Hybrid-VMAT for the Left-sided Breast Cancer for Sparing of the Left Anterior Descending (LAD) Coronary Artery | Mr. YU Kai Shing |
| 2014.067 | Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET)- A retrospective analysis of clinical features and survival in a tertiary hospital in Hong Kong and topic review | Dr. YU Kin Chap |
| 2016.197 | The effects of a structured multi-component program on pain and hand-grip strength in patients with tennis elbow: A pilot study. |
Mr. YU Kit Hong 余傑雄 |
| 2009.361 | The effectiveness of a heart failure management programme on patient clinical and psychological outcomes | Ms Yu Mingming |
| 2017.691 | Association between menstrual irregularity and bone mineral density in urban female residents: a cross-sectional pilot study |
Miss YU Qian 于谦 |
| 2013.290 | Effects of robot-assisted therapy using therapeutic robot Paro on moods, social interaction and communication in community-living older adults with mild to moderate dementia | Dr. YU Ruby |
| 2013.289 | Effects of the robot-assisted therapy using therapeutic robot Paro on behavioral and psychological symptoms in community-living older adults with moderate to severe dementia | Dr. YU Ruby |
| 2011.441 | Traditional Chinese mild body intervention in promoting health inolder community-living adults | Dr. YU Ruby |
| 2013.064 | Computer assisted intervention using touch-screen video game technology on cognitive and behavioral symptoms for community-living older adults with mild to moderate dementia | Dr. YU Ruby |
| 2023.024 | Effects of a multicomponent intervention on functional ability in community-dwelling older people: A randomized controlled trial | Dr. YU Ruby |
| 2017.132 | Comparisons between two exercise programs in pre-frail and frail Chinese elderly: a randomized controlled trial |
Dr. YU Ruby H.Y. 余浩欣 |
| 2017.114 | Frailty in daily practice: screening and consultation |
Dr. YU Ruby H.Y. 余浩欣 |
| 2016.528 | Evaluation of a Frailty Program in Hong Kong: A Randomized Controlled Trial and a Focus Group Study |
Dr. YU Ruby H.Y. 余浩欣 |
| 2017.577 | Evaluation of a computerized cognitive training program in older Chinese people: A randomized controlled trial |
Dr. YU Ruby H.Y. 余浩欣 |
| 2014.265 | A randomized controlled trial of a lifestyle intervention on frailty and cognitive functions in older Chinese adults with cognitive frailty | Dr. YU Ruby Ho Yan |
| 2014.264 | Traditional Chinese mind body intervention in promoting health in older community-living adults: A randomized controlled trial | Dr. YU Ruby Ho Yan |
| 2013.046 | Medication management among community-dwelling Chinese older people with multi-comorbidity | Dr Yu Sau Fung, Doris |
| 2014.228 | Psychometric evaluation of the Family Attitude Scale among Chinese family caregiver of people with dementia | Prof. YU Sau-fung Doris |
Page 256 of 262.